Shire

Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Takeda
M&A
Shire
fruquintinib
Exkivity
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Wed, 10/18/23 - 07:37 pm
Takeda
AbbVie
Shire
M&A
legal
Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3
Fierce Biotech
Mon, 02/6/23 - 10:29 am
Certa Therapeutics
Shire
FT011
autoimmune disease
clinical trials
scleroderma
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Fierce Biotech
Tue, 02/1/22 - 10:33 am
Takeda
HilleVax
Oak Hill Bio
Shire
M&A
FDA offers support for Takeda's potential cytomegalovirus drug ahead of adcomm
Endpoints
Wed, 10/6/21 - 11:17 pm
Takeda
FDA
CMV
post-transplant cytomegalovirus
Shire
maribavir
Former Shire asset becomes Mirum’s first FDA-approved rare disease drug
MedCity News
Thu, 09/30/21 - 10:47 am
Mirum Pharmaceuticals
Livmarli
Alagille syndrome
Shire
FDA
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Fierce Pharma
Tue, 09/14/21 - 10:34 pm
AbbVie
Shire
hedge funds
M&A
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Mon, 08/2/21 - 09:40 pm
Takeda
AbbVie
Shire
taxes
M&A
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Fri, 05/21/21 - 10:51 am
Shire
Takeda
M&A
CMV
maribavir
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
Fierce Pharma
Tue, 08/18/20 - 11:13 am
Takeda
Japan
early retirement
Shire
M&A
Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale
Endpoints
Tue, 07/7/20 - 08:22 pm
Takeda
Shire
M&A
OTC
Takeda continues post-Shire selloff, inching closer to $10B goal
Endpoints
Thu, 06/11/20 - 12:16 pm
Takeda
Celltrion
M&A
Shire
South Korea
Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead
Endpoints
Fri, 05/29/20 - 10:45 am
Takeda
IBD
SHP647
Shire
Takeda posts surprise profit a year after Shire mega-merger
Pharmaforum
Wed, 05/13/20 - 10:52 am
Japan
Takeda
Shire
M&A
earnings
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Oyster Point Pharma
dry eye disease
OC-01
Allergan
Restasis
Shire
Xiidra
Former Shire execs set up shop to take a shot at 'under the radar' cancer target
Endpoints
Wed, 03/18/20 - 10:06 am
cancer
oncology
Shire
OncoOne
Takeda Pharmaceutical Raises Its Profit Outlook
Motley Fool
Tue, 02/4/20 - 11:21 pm
Takeda
earnings
Shire
Takeda puts Shire biologics plant with 200 employees on the block
Fierce Pharma
Fri, 01/31/20 - 11:00 am
Shire
Takeda
drug manufacturing
Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Fri, 10/18/19 - 09:50 am
Takeda
Shire
M&A
layoffs
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m
Pharmaforum
Tue, 10/15/19 - 09:49 am
Takeda
Shire
M&A
Acino
Middle East
Africa

Pages